TIL insider filings

Instil Bio, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-06-12. Screen TIL transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for TIL between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Instil Bio, Inc.

FiledFormInsiderReported transactionsSource
2026-06-124Matcham George — DirectorGrant/award (A): 6,500 (derivative) @ $0EDGAR
2026-06-124Binder Gwendolyn — DirectorGrant/award (A): 6,500 (derivative) @ $0EDGAR
2026-06-124Gibson Neil W — DirectorGrant/award (A): 0 (derivative) @ $0EDGAR
2026-06-124McGaughy R Kent Jr — DirectorGrant/award (A): 6,500 (derivative) @ $0EDGAR
2025-09-124Laumas Sandeep — CFO and CBOOption exercise (M): 17,000 @ $11.60 · Option exercise (M): 13,000 @ $12.68 · Sale (S): 17,539 @ $23.04 · Sale (S): 12,461 @ $23.88 · Option exercise (M): 17,000 (derivative) @ $0 · Option exercise (M): 13,000 (derivative) @ $0EDGAR
2025-05-294Binder Gwendolyn — DirectorGrant/award (A): 6,500 (derivative) @ $0EDGAR
2025-05-294Matcham George — DirectorGrant/award (A): 6,500 (derivative) @ $0EDGAR
2025-05-294Gibson Neil W — DirectorGrant/award (A): 6,500 (derivative) @ $0EDGAR
2025-05-294McGaughy R Kent Jr — DirectorGrant/award (A): 6,500 (derivative) @ $0EDGAR
2025-04-284Crouch Bronson — CEO and Chairman, Director, 10% ownerGrant/award (A): 105,157 (derivative) @ $0EDGAR
2025-04-284Laumas Sandeep — CFO and CBOGrant/award (A): 44,851 (derivative) @ $0EDGAR
2024-09-234Crouch Bronson — CEO and Chairman, Director, 10% ownerGrant/award (A): 50,000 (derivative) @ $0EDGAR
2024-09-234Laumas Sandeep — CFO and CBOGrant/award (A): 45,000 (derivative) @ $0EDGAR
2024-06-134Matcham George — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2024-06-134Binder Gwendolyn — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2024-06-134Gibson Neil W — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2024-06-134McGaughy R Kent Jr — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2024-02-134Crouch Bronson — CEO and Chairman, Director, 10% ownerGrant/award (A): 120,000 (derivative) @ $0EDGAR
2024-02-134Laumas Sandeep — CFO and CBOGrant/award (A): 80,000 (derivative) @ $0EDGAR
2024-01-104Binder Gwendolyn — DirectorGrant/award (A): 1,500 (derivative) @ $0EDGAR
2024-01-104Matcham George — DirectorGrant/award (A): 1,500 (derivative) @ $0EDGAR
2024-01-104Nielsen Jack — DirectorGrant/award (A): 1,500 (derivative) @ $0EDGAR
2024-01-104Gibson Neil W — DirectorGrant/award (A): 1,500 (derivative) @ $0EDGAR
2024-01-104McGaughy R Kent Jr — DirectorGrant/award (A): 1,500 (derivative) @ $0EDGAR
2023-01-204Crouch Bronson — CEO and Chairman, Director, 10% ownerGrant/award (A): 1,000,000 (derivative) @ $0EDGAR
2023-01-204/ACrouch Bronson — CEO and Chairman, Director, 10% ownerGrant/award (A): 750,000 (derivative) @ $0EDGAR
2023-01-204Laumas Sandeep — CFO and CBOGrant/award (A): 415,000 (derivative) @ $0EDGAR
2023-01-204/ALaumas Sandeep — CFO and CBOGrant/award (A): 234,000 (derivative) @ $0EDGAR
2023-01-204Ray Sumita — Chief Legal and Admin OfficerGrant/award (A): 415,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0EDGAR
2022-09-064MOORE TIMOTHY L. — Chief Operating OfficerGrant/award (A): 750,000 (derivative) @ $0EDGAR
2022-05-254Chiruvolu Vijay — Chief Technical OfficerGrant/award (A): 154,237 (derivative) @ $0EDGAR
2022-05-254Binder Gwendolyn — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2022-05-254Matcham George — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2022-05-254Nielsen Jack — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2022-05-254Gibson Neil W — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2022-05-254McGaughy R Kent Jr — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2022-03-174McGaughy R Kent Jr — DirectorOther (J): 260,323 @ $0EDGAR
2022-03-074Roberts Zachary — Chief Medical OfficerGrant/award (A): 245,000 (derivative) @ $8.62EDGAR
2022-03-074Crouch Bronson — CEO and Chairman, Director, 10% ownerGrant/award (A): 750,000 (derivative) @ $8.62EDGAR
2022-03-074Chiruvolu Vijay — Chief Technical OfficerGrant/award (A): 257,000 (derivative) @ $8.62EDGAR
2022-03-074Laumas Sandeep — CFO and CBOGrant/award (A): 234,000 (derivative) @ $8.62EDGAR
2021-10-084Roberts Zachary — Chief Medical OfficerGrant/award (A): 120,000 (derivative) @ $0EDGAR
2021-09-134Roberts Zachary — Chief Medical OfficerGrant/award (A): 120,000 (derivative) @ $0EDGAR
2021-05-134Chiruvolu Vijay — Chief Technical OfficerGrant/award (A): 154,237 (derivative) @ $0 · Grant/award (A): 200,000 (derivative) @ $0EDGAR
2021-05-134Roberts Zachary — Chief Medical OfficerGrant/award (A): 200,000 (derivative) @ $0EDGAR
2021-05-134Crouch Bronson — CEO and Chairman, Director, 10% ownerGrant/award (A): 750,000 (derivative) @ $0EDGAR
2021-05-134Laumas Sandeep — CFO and CBOGrant/award (A): 200,000 (derivative) @ $0EDGAR
2021-03-254Shah Nimish P — DirectorConversion (C): 5,100,866 · Conversion (C): 510,030 · Conversion (C): 430,431 · Conversion (C): 43,033 · Conversion (C): 480,716 · Purchase (P): 104,640 @ $20 · +9 moreEDGAR
2021-03-254Nielsen Jack — DirectorConversion (C): 11,709,696 · Conversion (C): 477,091 · Purchase (P): 300,000 @ $20 · Conversion (C): 9,758,080 (derivative) @ $0 · Conversion (C): 397,576 (derivative) @ $0EDGAR
2021-03-254McGaughy R Kent Jr — DirectorConversion (C): 7,074,608 · Conversion (C): 954,182 · Purchase (P): 450,000 @ $20 · Conversion (C): 5,895,507 (derivative) @ $0 · Conversion (C): 795,152 (derivative) @ $0EDGAR

Recent 8-K events — Instil Bio, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-168-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-118-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-158-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-038-K4.01 — Changes in Registrant's Certifying Accountant
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-278-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-068-K1.02 — Termination of a Material Definitive AgreementEDGAR
2025-11-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-08-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-07-318-K8.01 — Other EventsEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=TIL returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs